Sofia R. Gameiro

4.6k total citations
59 papers, 2.7k citations indexed

About

Sofia R. Gameiro is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sofia R. Gameiro has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 42 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Sofia R. Gameiro's work include Cancer Immunotherapy and Biomarkers (43 papers), Immunotherapy and Immune Responses (27 papers) and CAR-T cell therapy research (19 papers). Sofia R. Gameiro is often cited by papers focused on Cancer Immunotherapy and Biomarkers (43 papers), Immunotherapy and Immune Responses (27 papers) and CAR-T cell therapy research (19 papers). Sofia R. Gameiro collaborates with scholars based in United States, India and Italy. Sofia R. Gameiro's co-authors include James W. Hodge, Jeffrey Schlom, Soldano Ferrone, Karin M. Knudson, Kwong Y. Tsang, Claudia Palena, Kristin C. Hicks, Max M. Wattenberg, Anna Kwilas and Momodou L. Jammeh and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sofia R. Gameiro

58 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia R. Gameiro United States 28 1.9k 1.5k 609 556 296 59 2.7k
Simon J. Dovedi United Kingdom 24 2.0k 1.1× 1.4k 0.9× 416 0.7× 578 1.0× 252 0.9× 60 2.8k
Maria Jure–Kunkel United States 21 2.3k 1.2× 2.0k 1.3× 498 0.8× 379 0.7× 199 0.7× 42 3.0k
Anusha Kalbasi United States 18 1.5k 0.8× 1.2k 0.8× 545 0.9× 695 1.3× 214 0.7× 62 2.6k
Karsten A. Pilones United States 16 1.4k 0.8× 1.1k 0.7× 449 0.7× 342 0.6× 241 0.8× 41 2.0k
Colm R. Duffy United States 4 1.6k 0.9× 1.1k 0.7× 514 0.8× 394 0.7× 111 0.4× 11 2.3k
Gheath Alatrash United States 24 1.8k 1.0× 1.3k 0.8× 674 1.1× 385 0.7× 232 0.8× 126 2.9k
Ross Stewart United Kingdom 18 1.9k 1.0× 842 0.5× 378 0.6× 631 1.1× 338 1.1× 46 2.4k
Jonathan J. Havel United States 13 1.9k 1.0× 1.1k 0.7× 825 1.4× 683 1.2× 145 0.5× 14 2.7k
Riccardo Danielli Italy 22 1.4k 0.7× 1.0k 0.7× 728 1.2× 621 1.1× 192 0.6× 45 2.4k
Marcella Fassò United States 25 2.1k 1.1× 1.3k 0.9× 357 0.6× 725 1.3× 124 0.4× 42 2.9k

Countries citing papers authored by Sofia R. Gameiro

Since Specialization
Citations

This map shows the geographic impact of Sofia R. Gameiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia R. Gameiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia R. Gameiro more than expected).

Fields of papers citing papers by Sofia R. Gameiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia R. Gameiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia R. Gameiro. The network helps show where Sofia R. Gameiro may publish in the future.

Co-authorship network of co-authors of Sofia R. Gameiro

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia R. Gameiro. A scholar is included among the top collaborators of Sofia R. Gameiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia R. Gameiro. Sofia R. Gameiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lassoued, Wiem, et al.. (2025). Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy. Journal for ImmunoTherapy of Cancer. 13(5). e011074–e011074. 1 indexed citations
2.
Goswami, Meghali, Christine M. Minnar, Dara Bracken‐Clarke, et al.. (2025). Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy. Clinical Cancer Research. 31(19). 4159–4173. 1 indexed citations
3.
Schlom, Jeffrey, Renee N. Donahue, Claudia Palena, et al.. (2024). Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for ImmunoTherapy of Cancer. 12(7). e009595–e009595.
4.
Chariou, Paul L., Christine M. Minnar, Mayank Tandon, et al.. (2024). Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9. PLoS ONE. 19(3). e0287733–e0287733. 1 indexed citations
5.
Minnar, Christine M., Paul L. Chariou, Lucas A. Horn, et al.. (2022). Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. Journal for ImmunoTherapy of Cancer. 10(6). e004561–e004561. 34 indexed citations
6.
Robbins, Yvette, Xinping Yang, Wojciech K. Mydlarz, et al.. (2022). Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity. JCI Insight. 7(5). 10 indexed citations
7.
Hicks, Kristin C., Paul L. Chariou, Yohei Ozawa, et al.. (2021). Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape. Nature Communications. 12(1). 5151–5151. 58 indexed citations
8.
Gatti‐Mays, Margaret E., Sofia R. Gameiro, Yohei Ozawa, et al.. (2021). Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer. Frontiers in Oncology. 10. 581801–581801. 20 indexed citations
9.
Hicks, Kristin C., Karin M. Knudson, Karin L. Lee, et al.. (2019). Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy. Clinical Cancer Research. 26(3). 704–716. 37 indexed citations
10.
Lee, Karin L., Stephen C. Benz, Kristin C. Hicks, et al.. (2019). Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. Cancer Immunology Research. 7(8). 1359–1370. 20 indexed citations
11.
Knudson, Karin M., Kristin C. Hicks, Sarah Alter, Jeffrey Schlom, & Sofia R. Gameiro. (2019). Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy. Journal for ImmunoTherapy of Cancer. 7(1). 82–82. 87 indexed citations
12.
Friedman, Jay, Megan V. Morisada, Lillian Sun, et al.. (2018). Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. Journal for ImmunoTherapy of Cancer. 6(1). 59–59. 43 indexed citations
13.
Ardiani, Andressa, Sofia R. Gameiro, Claudia Palena, et al.. (2014). Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process. Cancer Research. 74(7). 1945–1957. 29 indexed citations
14.
Bernstein, M., Charlie Garnett‐Benson, Anna Velcich, et al.. (2014). Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions. Cancer Biotherapy and Radiopharmaceuticals. 29(4). 153–161. 69 indexed citations
15.
Garnett‐Benson, Charlie, James W. Hodge, & Sofia R. Gameiro. (2014). Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities. Seminars in Radiation Oncology. 25(1). 46–53. 26 indexed citations
16.
Gameiro, Sofia R., Andressa Ardiani, Anna Kwilas, & James W. Hodge. (2014). Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens. OncoImmunology. 3(5). e28643–e28643. 43 indexed citations
17.
Gameiro, Sofia R., Jack P. Higgins, Matthew R. Dreher, et al.. (2013). Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression. PLoS ONE. 8(7). e70417–e70417. 57 indexed citations
18.
Hodge, James W., Hadley J. Sharp, & Sofia R. Gameiro. (2012). Abscopal Regression of Antigen Disparate Tumors by Antigen Cascade After Systemic Tumor Vaccination in Combination with Local Tumor Radiation. Cancer Biotherapy and Radiopharmaceuticals. 27(1). 12–22. 97 indexed citations
19.
Hodge, James W., Andressa Ardiani, Benedetto Farsaci, Anna Kwilas, & Sofia R. Gameiro. (2012). The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors. Seminars in Oncology. 39(3). 323–339. 113 indexed citations
20.
Gameiro, Sofia R., et al.. (2012). Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing. Cancer Biotherapy and Radiopharmaceuticals. 27(1). 23–35. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026